 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. It operates through Human Therapeutics segment. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.

Current Price	$218.53
Prev Close	$216.93
Open	$215.03
Dividend Yield	2.95%
50-Day Moving Average	$237.07
Beta	0.47
Avg. Volume	1.95M
PE Ratio	14.85

52-Week High	$296.67
52-Week Low	$214.48
Market Capitalization	$116.77B
EPS	$14.71
Price to Book	21.83
Revenue Per Employee	$1.03M
Enterprise Value/EBITDA	13.09

AMGN AMGEN Inc.

About

Feed

Fundamentals

News